{"id":"doi:10.1056/nejmoa1812792","kind":"article","title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","authors":["Deepak L. Bhatt","Philippe Gabríel Steg","Michael J. Miller","Eliot A. Brinton","Terry A. Jacobson","Steven B. Ketchum","Ralph T. Doyle","Rebecca A. Juliano","Lixia Jiao","Craig B. Granowitz","Jean‐Claude Tardif","Christie Mitchell Ballantyne"],"author_count":12,"year":2018,"published":"2018-11-10","venue":"New England Journal of Medicine","cited_by":3316,"doi":"10.1056/nejmoa1812792","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa1812792","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa1812792","updated":null,"pmid":"30415628","pmcid":null,"openalex_id":"W2899669642","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Fatty Acid Research and Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}